Harvard Apparatus Regenerative Technology, Inc. (HRGN)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD.

Revenue Quarterly

0 150K 300K 450K Q3 '24: 59K Q4 '24: 258K Q1 '25: 45K Q2 '25: 317K Q3 '25: 123K Q4 '25: 219K Q1 '26: 226K Q2 '26: 414K Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26

Gross Profit Quarterly

-45K -30K -15K 0 15K 30K 45K Q1 '16: 0 Q2 '16: -16K Q3 '16: 13K Q4 '16: -31K Q1 '17: 0 Q2 '17: 0 Q3 '17: 0 Q4 '17: 0 Q1 '16 Q2 '16 Q3 '16 Q4 '16 Q1 '17 Q2 '17 Q3 '17 Q4 '17

Operating Income Quarterly

-2.1M -1.4M -700K 0 700K 1.4M 2.1M Q3 '24: -1.9M Q4 '24: -1.4M Q1 '25: -1.7M Q2 '25: -1.8M Q3 '25: -1.7M Q4 '25: -1.7M Q1 '26: -1.6M Q2 '26: -1.7M Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26

Net Income Quarterly

-2.1M -1.4M -700K 0 700K 1.4M 2.1M Q3 '24: -1.9M Q4 '24: -1.3M Q1 '25: -1.7M Q2 '25: -1.8M Q3 '25: -1.7M Q4 '25: -1.7M Q1 '26: -1.6M Q2 '26: -1.7M Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26

Cost of Revenue Quarterly

0 150K 300K 450K Q3 '24: 70K Q4 '24: 175K Q1 '25: 33K Q2 '25: 302K Q3 '25: 112K Q4 '25: 199K Q1 '26: 206K Q2 '26: 391K Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26

Operating Cash Flow Quarterly

-1.8M -1.2M -600K 0 600K 1.2M 1.8M Q3 '24: -1.5M Q4 '24: -1.1M Q1 '25: -758K Q2 '25: -941K Q3 '25: -1.5M Q4 '25: -664K Q1 '26: -937K Q2 '26: -569K Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26

Free Cash Flow Quarterly

-4.5M -3M -1.5M 0 1.5M 3M 4.5M Q3 '20: -862K Q4 '20: -1M Q4 '21: -1M Q3 '22: -1.7M Q1 '23: -1M Q2 '23: -1.5M Q3 '23: -3.2M Q4 '23: -1.2M Q3 '20 Q4 '20 Q4 '21 Q3 '22 Q1 '23 Q2 '23 Q3 '23 Q4 '23

Operating cash flow minus capital expenditure.

Shares Outstanding Quarterly

0 6M 12M 18M Q1 '24: 13.9M Q2 '24: 14.3M Q3 '24: 15M Q1 '25: 15.9M Q2 '25: 15.9M Q3 '25: 17M Q1 '26: 17.6M Q2 '26: 17.6M Q1 '24 Q2 '24 Q3 '24 Q1 '25 Q2 '25 Q3 '25 Q1 '26 Q2 '26

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

-0.60 -0.40 -0.20 0.00 0.20 0.40 0.60 Q3 '24: -0.58 Q4 '24: -0.53 Q1 '25: -0.48 Q2 '25: -0.41 Q3 '25: -0.39 Q4 '25: -0.41 Q1 '26: -0.40 Q2 '26: -0.39 Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.